OOIR: Observatory of International Research

Papers

(The H4-Index of Current Neuropharmacology is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease	335
Role of Nuclear Factor Kappa B (NF-κB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach	160
Crosstalk between Inflammation and the BBB in Stroke	94
Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective	87
Angiogenesis and Blood-Brain Barrier Permeability in Vascular Remodeling after Stroke	83
Effects of Withania somnifera (Ashwagandha) on Stress and the Stress- Related Neuropsychiatric Disorders Anxiety, Depression, and Insomnia	71
A Scientometrics Analysis and Visualization of Depressive Disorder	64
Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled	60
The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress	58
Role of Nitric Oxide in Neurodegeneration: Function, Regulation, and Inhibition	53
The Dual Role of Microglia in Blood-Brain Barrier Dysfunction after Stroke	53
PTSD in the COVID-19 Era	50
Depression and Pain: Use of Antidepressants	50
Mitochondrial Dysfunction in Alzheimer’s Disease: Opportunities for Drug Development	50
The Stroke-Induced Blood-Brain Barrier Disruption: Current Progress of Inspection Technique, Mechanism, and Therapeutic Target	48
Potential Mechanisms and Clinical Effectiveness of Acupuncture in Depression	48
Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications	47
Exosomes as a Promising Therapeutic Strategy for Peripheral Nerve Injury	43
5-HT3 Receptor Antagonism: A Potential Therapeutic Approach for the Treatment of Depression and other Disorders	42
Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations	41
Neuroinflammation in Huntington’s Disease: A Starring Role for Astrocyte and Microglia	38
Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation	38
Glia-Driven Neuroinflammation and Systemic Inflammation in Alzheimer’s Disease	37
Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease	37
C-Phycocyanin-derived Phycocyanobilin as a Potential Nutraceutical Approach for Major Neurodegenerative Disorders and COVID-19- induced Damage to the Nervous System	34

Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review	33
Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer’s and Parkinson’s Diseases	33
The Effects of General Anesthetics on Synaptic Transmission	33
Underlying Mechanisms and Potential Therapeutic Molecular Targets in Blood-Brain Barrier Disruption after Subarachnoid Hemorrhage	31
Inhibition of Caspase 3 and Caspase 9 Mediated Apoptosis: A Multimodal Therapeutic Target in Traumatic Brain Injury	31
Off-label Uses of Selective Serotonin Reuptake Inhibitors (SSRIs)	31
The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection	31
Association of Oxidative Stress with Neurological Disorders	31